Immunobiology of human mucin 1 in a preclinical ovarian tumor model

MUC1 Enhances Tumor Progression and Contributes Toward Immunosuppression in a Mouse Model of Spontaneous Pancreatic Adenocarcinoma

(2014) T. L. Tinder et al.   JOURNAL OF IMMUNOLOGY

Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer

(2011) Raluca A. Budiu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Pancreatic Ductal Adenocarcinoma Mice Lacking Mucin 1 Have a Profound Defect in Tumor Growth and Metastasis

(2011) D. M. Besmer et al.   CANCER RESEARCH

Epithelial ovarian cancer: Focus on genetics and animal models

(2011) Weiwei Shan et al.   CELL CYCLE

Engagement of the Mannose Receptor by Tumoral Mucins Activates an Immune Suppressive Phenotype in Human Tumor-Associated Macrophages

(2011) P. Allavena et al.   Clinical & Developmental Immunology

CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells

(2011) Silke Reinartz et al.   EUROPEAN JOURNAL OF CANCER

MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis

(2011) Catherine Thériault et al.   GYNECOLOGIC ONCOLOGY

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm

(2011) Robert J. Kurman et al.   HUMAN PATHOLOGY

Recent Developments in Cancer Vaccines

(2011) K. Palucka et al.   JOURNAL OF IMMUNOLOGY

Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo

(2011) L K Mullany et al.   ONCOGENE

Mammalian Target of Rapamycin Is a Therapeutic Target for Murine Ovarian Endometrioid Adenocarcinomas with Dysregulated Wnt/β-Catenin and PTEN

(2011) Pradeep S. Tanwar et al.   PLoS One

Expression of aberrantly glycosylated Mucin-1 in ovarian cancer

(2010) Catharina H M J Van Elssen et al.   HISTOPATHOLOGY

Immunotherapy for Ovarian Cancer: What's Next?

(2010) Lana E. Kandalaft et al.   JOURNAL OF CLINICAL ONCOLOGY

Ovarian cancer: the duplicity of CA125 measurement

(2010) Amer K. Karam et al.   Nature Reviews Clinical Oncology

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition

(2010) L D Roy et al.   ONCOGENE

Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines

(2009) Adam S. Giermasz et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Epithelial–mesenchymal transition in ovarian cancer

(2009) Daniele Vergara et al.   CANCER LETTERS

MUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor- B p65 Transcription Factor

(2009) R. Ahmad et al.   CANCER RESEARCH

Cell Type-Specific Targeted Mutations of Kras and Pten Document Proliferation Arrest in Granulosa Cells versus Oncogenic Insult to Ovarian Surface Epithelial Cells

(2009) H.-Y. Fan et al.   CANCER RESEARCH

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells

(2009) R. A. Budiu et al.   Disease Models & Mechanisms

Cancer Immunotherapy by Dendritic Cells

(2008) Cornelis J.M. Melief   IMMUNITY